Woo S, Garzon J, Sanchez-Blazquez P, Tulunay F C, Chang J K, Loh H H
Life Sci. 1982;31(16-17):1817-20. doi: 10.1016/0024-3205(82)90218-1.
Dynorphin(1-10)amide was more potent than Dynorphin(1-13) in inhibiting the twitch of the mouse vas deferens (IC50 of Dynorphin(1-10)amide = 0.3 nM and IC50 of Dynorphin (1-13) = 4.0 nM). Binding assays indicated that two opioid peptides had similar profiles in that they enhanced dihydromorphine (DHM) binding in picomolar concentrations but displaced DHM binding in nanomolar concentrations (IC50 for Dynorphin(1-10)amide = 5 nM). In the mouse tail-flick assay, however, Dynorphin(1-10)amide showed a more selective action on morphine-induced analgesia. Although Dynorphin(1-10)amide had no significant analgesic activity by itself, it differed from the (1-13) analog by neither potentiating nor antagonizing morphine in naive animals. In tolerant animals, on the other hand, 50 microgram of this analog administered icv shifted the ED50 of morphine from 43.0(33.0-55.9) to 17.0 (12.4-23.3). Thus, Dynorphin(1-10)amide appears to be a more potent and selective analog of Dynorphin(1-13).
强啡肽(1-10)酰胺在抑制小鼠输精管抽搐方面比强啡肽(1-13)更有效(强啡肽(1-10)酰胺的IC50 = 0.3 nM,强啡肽(1-13)的IC50 = 4.0 nM)。结合试验表明,两种阿片肽具有相似的特征,即它们在皮摩尔浓度下增强二氢吗啡(DHM)结合,但在纳摩尔浓度下取代DHM结合(强啡肽(1-10)酰胺的IC50 = 5 nM)。然而,在小鼠甩尾试验中,强啡肽(1-10)酰胺对吗啡诱导的镇痛表现出更具选择性的作用。尽管强啡肽(1-10)酰胺本身没有明显的镇痛活性,但它与(1-13)类似物的不同之处在于,在未用药的动物中既不增强也不拮抗吗啡。另一方面,在耐受性动物中,脑室内注射50微克这种类似物可使吗啡的ED50从43.0(33.0 - 55.9)变为17.0(12.4 - 23.3)。因此,强啡肽(1-10)酰胺似乎是强啡肽(1-13)更有效和更具选择性的类似物。